An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...

Dr Devon Conway describes how the upcoming conference is expected to provide important new data on the safety and real-world ...

SHREVEPORT, La. - A cutting-edge clinical trial is now underway in Shreveport, and local patients with Multiple Sclerosis are ...

Multiple sclerosis, an autoimmune condition, causes the immune system to mistakenly attack myelin cells, which are protective ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of ...

SHREVEPORT, La. - The Center for Molecular Imaging and Therapy, a subsidiary of BRF, proudly announces its new collaboration ...

After her own multiple sclerosis diagnosis 10 years ago, Parisa Khosravi became an advocate and a clinician for an autoimmune ...

Learn how autologous hematopoietic stem cell transplantation (aHSCT) offers hope in MS treatment, its effectiveness, who qualifies, and availability in the United States.